We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.
- Authors
Sarry, Jean-Emmanuel; Murphy, Kathleen; Perry, Robin; Sanchez, Patricia V.; Secreto, Anthony; Keefer, Cathy; Swider, Cezary A.; Strzelecki, Anne-Claire; Cavelier, Cindy; Récher, Christian; Mansat-De Mas, Véronique; Delabesse, Eric; Danet-Desnoyers, G.; Carroll, Martin; Swider, Cezary R; Récher, Christian; Mansat-De Mas, Véronique
- Abstract
Human leukemic stem cells, like other cancer stem cells, are hypothesized to be rare, capable of incomplete differentiation, and restricted to a phenotype associated with early hematopoietic progenitors or stem cells. However, recent work in other types of tumors has challenged the cancer stem cell model. Using a robust model of xenotransplantation based on NOD/SCID/IL2Rγc-deficient mice, we confirmed that human leukemic stem cells, functionally defined by us as SCID leukemia-initiating cells (SL-ICs), are rare in acute myelogenous leukemia (AML). In contrast to previous results, SL-ICs were found among cells expressing lineage markers (i.e., among Lin+ cells), CD38, or CD45RA, all markers associated with normal committed progenitors. Remarkably, each engrafting fraction consistently recapitulated the original phenotypic diversity of the primary AML specimen and contained self-renewing leukemic stem cells, as demonstrated by secondary transplants. While SL-ICs were enriched in the Lin-CD38- fraction compared with the other fractions analyzed, SL-ICs in this fraction represented only one-third of all SL-ICs present in the unfractionated specimen. These results indicate that human AML stem cells are rare and enriched but not restricted to the phenotype associated with normal primitive hematopoietic cells. These results suggest a plasticity of the cancer stem cell phenotype that we believe has not been previously described.
- Subjects
LEUKEMIA; CANCER cells; PHENOTYPES; TUMORS; XENOTRANSPLANTATION; ACUTE myeloid leukemia; STEM cells; STEM cell transplantation; ANIMAL experimentation; BIOLOGICAL models; CELL differentiation; CELL receptors; COMPARATIVE studies; DNA probes; HEMATOPOIETIC stem cells; IMMUNOPHENOTYPING; RESEARCH methodology; MEDICAL cooperation; MICE; NUCLEOTIDES; RESEARCH; RESEARCH funding; XENOGRAFTS; EVALUATION research; PHYSIOLOGY
- Publication
Journal of Clinical Investigation, 2011, Vol 121, Issue 1, p384
- ISSN
0021-9738
- Publication type
journal article
- DOI
10.1172/JCI41495